Management of diabetes mellitus in patients undergoing liver transplantation

Valeria Grancini, Veronica Resi, Eva Palmieri, Giuseppe Pugliese, Emanuela Orsi

Research output: Contribution to journalReview articlepeer-review

Abstract

Diabetes is a common feature in cirrhotic individuals both before and after liver transplantation and negatively affects prognosis. Certain aetiological agents of chronic liver disease and loss of liver function per se favour the occurrence of pre-transplant diabetes in susceptible individuals, whereas immunosuppressant treatment, changes in lifestyle habits, and donor- and procedure-related factors contribute to diabetes development/persistence after transplantation. Challenges in the management of pre-transplant diabetes include the profound nutritional alterations characterizing cirrhotic individuals and the limitations to the use of drugs with liver metabolism. Special issues in the management of post-transplant diabetes include the diabetogenic potential of immunosuppressant drugs and the increased cardiovascular risk characterizing solid organ transplant survivors. Overall, the pharmacological management of cirrhotic patients undergoing liver transplantation is complicated by the lack of specific guidelines reflecting the paucity of data on the impact of glycaemic control and the safety and efficacy of anti-hyperglycaemic agents in these individuals.

Original languageEnglish
Pages (from-to)556-573
Number of pages18
JournalPharmacological Research
Volume141
DOIs
Publication statusPublished - Mar 1 2019

Keywords

  • Acarbose (PubChem CID: 444254)
  • Anti-hyperglycaemic drugs
  • Canagliflozin (PubChem CID: 24812758)
  • Dapagliflozin (PubChem CID: 9887712)
  • Diabetes mellitus
  • Empagliflozin (PubChem CID: 11949646)
  • Exenatide (PubChem CID: 45588096)
  • Immunosuppressant drugs
  • Lifestyle intervention
  • Linagliptin (PubChem CID: 10096344)
  • Liraglutide (PubChem CID: 16134956)
  • Liver transplantation
  • Metformin (PubChem CID: 4091)
  • Pioglitazone (PubChem CID: 4829)
  • Sitagliptin (PubChem CID: 4369359)

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Management of diabetes mellitus in patients undergoing liver transplantation'. Together they form a unique fingerprint.

Cite this